A study mapped TDP-43 fragments in Alzheimer’s disease and age-related tauopathy
Original source
Structural Heterogeneity of TDP-43 Fragments in Alzheimer's Disease and Primary Age-Related Tauopathy by Artificial Intelligence (AI)-Based 3D Segmentation. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Human
Related topics
Researchers used three-dimensional imaging and artificial intelligence to measure different TDP-43 fragments in brain regions from people with low-likelihood Alzheimer’s disease and primary age-related tauopathy. The fragments showed distinct patterns across the amygdala, hippocampus and entorhinal cortex.
Why this matters
The findings add detail about how TDP-43 pathology can differ between neurodegenerative conditions. The study did not examine people with amyotrophic lateral sclerosis (ALS), so it does not change ALS diagnosis or treatment.
Limitations and context
This was a pathology study of Alzheimer’s disease and primary age-related tauopathy, not an ALS study or a treatment trial. The supplied source does not report the number of participants or establish whether the fragment patterns affect symptoms, disease progression or treatment response.